BASF shuts ibuprofen production at US plant due to technical problem
FRANKFURT: German chemicals group BASF has shut down production of ibuprofen at its plant in Bishop, Texas because of a technical problem, a spokesman for BASF said.
The spokesman said it could take until early September to fix the problem at the plant, where ibuprofen production has been shut down since June 3.
BASF last year announced plans to invest around 200 million euros ($232.74 million) in a new ibuprofen plant at its headquarters in Ludwigshafen in Germany and to expand the Bishop site’s production capacity.
It said at the time that the investment would make it the only company worldwide making ibuprofen at more than one plant. The new facility in Germany is scheduled to come online in 2021.
(Reporting by Maria Sheahan. Editing by Jane Merriman)
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd